162 - Fresh New Results On Old and New Vaccines

Moderator(s)

• 

  Ahmed Babiker, MBBS, MSc

  Assistant Professor
  Division of Infectious Disease, Department of Medicine
  Rush University Medical Center
  Chicago, IL, United States
• 

  Angela Campbell, MD, MPH, FPIDS, FIDSA

  Adjunct Professor of Pediatrics
  Emory University School of Medicine

Presentations:

• 1:45 PM - 1:57 PM US ET

  Effectiveness of the JN.1-adapted BNT162b2 COVID-19 Vaccine in High-Risk Groups against Hospitalization in Europe: A Test-Negative Case-Control using the id.DRIVE Platform
  

  Presenting Author: Hannah R. Volkman, PhD, MPH – Pfizer

  Co-Author: Leonie de Munter, PhD – P95 Epidemiology and Pharmacovigilance

  Co-Author: Thao M.P. Tran, PhD – P95 Clinical and Epidemiology Services

  Co-Author: Cátia Marques, MSc – Pfizer Inc.

  Co-Author: Elisabeth J. Mesfun-Kap, PhD – P95 Clinical and Epidemiology Services

  Co-Author: Laura Choi, MPH – Pfizer Inc.

  Co-Author: Hollie Dunford, BSc – P95 Clinical and Epidemiology Services

  Co-Author: Srinivas Valluri, PhD – Pfizer Inc

  Co-Author: Juan V. Hernandez-Villena, MSc – P95 Clinical and Epidemiology Services

  Co-Author: Jingyan Yang, MHS, DrPH – Pfizer and Columbia University Institute for Social and Economic Research and Policy

  Co-Author: Sultan Abduljawad, PhD – BioNTech UK Ltd.

  Co-Author: Irma Casas, PhD – Hospital Universitari Germans Trias i Pujol

  Co-Author: Elisa Martró, PhD – Hospital Universitari Germans Trias I Pujol

  Co-Author: Beate Grüner, MD – University Hospital Ulm

  Co-Author: Ainara Mira-Iglesias, PhD – Fisabio Public-Health

  Co-Author: Carlos M. Oñoro-López, MD – Hospital Universitario La Paz

  Co-Author: Oleguer Parés-Badell, MD – Hospital Universitari Vall d'Hebron

  Co-Author: Alejandro Orrico-Sánchez – FISABIO-Public Health

  Co-Author: Susana Otero-Romero, PhD – Hospital Universitario Vall d’Hebrón

  Co-Author: Antoni Torres, MD, PhD – Hospital Clinic, University of Barcelona, IDIBAPS, CIBERES

  Co-Author: Federico Martinon-Torres, MD, PhD, Assoc. Prof – Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain

  Co-Author: Jennifer L Nguyen, ScD, MPH – Pfizer Inc.

  Co-Author: Kaatje Bollaerts, PhD – P95 Epidemiology and Pharmacovigilance
• 1:57 PM - 2:09 PM US ET

  Cardiac Troponin I Levels Following mRNA-1273 Vaccination in Participants 12 Through 30 Years of Age: Results from a Phase 4 Randomized, Placebo-Controlled Study
  

  Presenting Author: Susan Pfeiffer, PA-C, MS – Moderna, Inc.

  Co-Author: Veronica Urdaneta, MD, MPH (she/her/hers) – Moderna, Inc.

  Co-Author: Xiaowei Wang, PhD – Moderna, Inc.

  Co-Author: Bethany Girard, Ph.D. – Moderna, Inc.

  Co-Author: Frances Priddy, MD, MPH (she/her/hers) – Moderna, Inc.

  Co-Author: Margaret Rhee, M.D. – Velocity Clinical Research

  Co-Author: Scott Striplin, MD – Velocity Clinical Research

  Co-Author: Spyros Chalkias, MD (he/him/his) – Moderna, Inc.
• 2:09 PM - 2:21 PM US ET

  Safety and Immunogenicity of Meningococcal Serogroup B Vaccine (4CMenB) and 13-Valent Pneumococcal Vaccine (PCV13) Administered Concomitantly with Routine Infant Vaccines (RIVs) to Healthy United States (US) Infants: A Randomized Controlled Study
  

  Presenting Author: Debasish Saha, MD, Phd – GSK Vaccines

  Co-Author: Laura Tomasi Cont, PhD – GSK

  Co-Author: Walter J. Rok, MD – Pediatric Associates of Fall River

  Co-Author: Judith M. Martin, MD (she/her/hers) – University of Pittsburgh

  Co-Author: Pavitra Keshavan, n/a – GSK

  Co-Author: Danielle Morelle, n/a – GSK

  Co-Author: Mauro Trapani, PharmaD – GSK

  Co-Author: Elisa Cinconze, n/a – GSK

  Co-Author: Maria Lattanzi, MD, PhD – GSK

  Co-Author: Daniela Toneatto, MD – GSK
• 2:21 PM - 2:33 PM US ET

  A Phase 3, Randomized, Modified Double-blind Study Demonstrates Immunological Superiority of High-Dose (HD) Over Standard-Dose (SD) Inactivated Influenza Vaccine (IIV) in Adults 50 Through 64 Years of Age
  

  Presenting Author: Rachna Gupta, MD, MPH, FIDSA – Sanofi

  Co-Author: Ashley Huang, MS – Sanofi

  Co-Author: Lisa Jackson, MD, MPH (she/her/hers) – Kaiser Permanente Washington Health Research Institute

  Co-Author: Stephanie Pepin, PhD – Sanofi

  Co-Author: Tamala mallet Moore, PhD – Sanofi

  Co-Author: Riyadh Obeng, PhD – Sanofi

  Co-Author: Beth Kelly, PhD – AstraZeneca

  Co-Author: Iris DeBruijn, PhD – Sanofi
• 2:33 PM - 2:45 PM US ET

  Preliminary results of 20-valent pneumococcal conjugate vaccine (PCV20) monitoring in children through 24 months of age in the Vaccine Safety Datalink
  

  Presenting Author: TatYana Kenigsberg, MPH – Centers for Disease Control and Prevention

  Co-Author: Elizabeth Quincer, MD, MPH – Centers for Disease Control and Prevention

  Co-Author: Lily Wang, MD, MS – Centers for Disease Control and Prevention

  Co-Author: Joshua T.B. Williams, MD – Denver Health

  Co-Author: Judith Maro, PhD – Harvard Pilgrim Health Care Institute

  Co-Author: Robyn Kaiser, MD, MPH – HealthPartners Institute

  Co-Author: Jill Inderstrodt, n/a – Indiana University

  Co-Author: Jason Glanz, n/a – Kaiser Permanente Colorado

  Co-Author: Tierra Oseji, n/a – Kaiser Permanente Mid-Atlantic States

  Co-Author: Lisa Jackson, MD, MPH (she/her/hers) – Kaiser Permanente Washington Health Research Institute

  Co-Author: Maria Sundaram, PhD, MSPH – Marshfield Clinic Research Institute

  Co-Author: Nicola P. Klein, MD, PhD (she/her/hers) – Division of Research Kaiser Permanente Vaccine Study Center

  Co-Author: Holly C. Groom, MPH – Kaiser Permanente Center for Health Research

  Co-Author: Teresa Schmidt, PhD – OCHIN

  Co-Author: Lei Qian, PhD – Kaiser Permanente Southern California

  Co-Author: Eric Weintraub, MPH – Centers for Disease Control and Prevention
• 2:45 PM - 2:57 PM US ET

  Phase 1/2 Trial of an Investigational Herpes Zoster Vaccine with CpG 1018® Adjuvant and Shingrix in Healthy Adults 50 to 69 Years of Age
  

  Presenting Author: Oliver Medzihradsky, MD MPH MS – Dynavax Technologies

  Co-Author: Rachel Graham, MBBS – Innovate Clinical Research

  Co-Author: Paul Nguyen, MBBS – Emeritus Research Melbourne

  Co-Author: Deon Smith, MBChB – Canopy Clinical Research Northern Beaches

  Co-Author: Paul Bird, BMed, PhD – Emeritus Research Sydney

  Co-Author: John D. Campbell, PhD – Dynavax Technologies

  Co-Author: Mohamed El Idrissi, MSc – Dynavax Technologies

  Co-Author: Ade Odueyungbo, PhD – Dynavax Technologies

  Co-Author: Ouzama Henry, MD MSc – Dynavax Technologies

  Co-Author: Robert Janssen, MD – Dynavax Technologies Corporation